Table 3.
Relationship between serum 25‐hydroxyvitamin D levels and the risk of metabolic syndrome
| Entire population | Women | Men | |||||||
|---|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P | |
| Model 1 | 0.99 | 0.97–1.00 | 0.046 | 1.00 | 0.97–1.02 | 0.83 | 0.97 | 0.94–0.99 | <0.01 |
| Model 2 | 0.98 | 0.96–1.00 | 0.01 | 1.00 | 0.98–1.02 | 0.88 | 0.96 | 0.94–0.99 | <0.01 |
| Model 3 | 0.98 | 0.96–0.99 | 0.01 | 1.00 | 0.97–1.02 | 0.84 | 0.96 | 0.94–0.98 | <0.01 |
Model 1: unadjusted. Model 2: adjusted for age, sex, cigarette smoking status, alcohol consumption and physical activity. Model 3: adjusted for the aforementioned plus total serum cholesterol, low‐density lipoprotein cholesterol and creatinine.CI, confidence interval; OR, odds ratio.